These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 7654091)
1. Case study of the anemic patient: epoetin alfa--focus on erythrokinetics. Chmielewski CM ANNA J; 1995 Aug; 22(4):420-3. PubMed ID: 7654091 [TBL] [Abstract][Full Text] [Related]
2. Case management of the anemic patient. Epoetin alfa: focus on hematocrit. Kirlin L ANNA J; 1992 Feb; 19(1):66-7. PubMed ID: 1546890 [TBL] [Abstract][Full Text] [Related]
3. Case management of the anemic patient. Epoetin alfa: focus on kinetic dosing. Keen ML ANNA J; 1990 Aug; 17(4):318-9. PubMed ID: 2396859 [TBL] [Abstract][Full Text] [Related]
4. Case management of the anemic patient. Epoetin alfa: focus on reimbursement. Roe WI ANNA J; 1992 Apr; 19(2):198-9. PubMed ID: 1586234 [TBL] [Abstract][Full Text] [Related]
5. Epoetin alfa: focus on maintaining a higher, stable, Hct. Case study of the anemic patient. Cohen JA; Brattich M ANNA J; 1997 Oct; 24(5):574-80; quiz 581. PubMed ID: 9392740 [TBL] [Abstract][Full Text] [Related]
6. Epoetin alfa--focus on optimal hematocrit. Case study of the anemic patient. Hendrix WR ANNA J; 1996 Feb; 23(1):46-9. PubMed ID: 8702361 [TBL] [Abstract][Full Text] [Related]
7. Administration of Epoetin alfa. Case study of the anemic patient. Cutler M ANNA J; 1997 Aug; 24(4):459-65; quiz 466. PubMed ID: 9325701 [TBL] [Abstract][Full Text] [Related]
8. Case management of the anemic patient: epoetin alfa--focus on adequacy of dialysis. Erlich L ANNA J; 1993 Apr; 20(2):181-4. PubMed ID: 8512376 [TBL] [Abstract][Full Text] [Related]
9. Case study of the anemic patient: epoetin alfa--focus on improving ventricular function. Weil C ANNA J; 1995 Jun; 22(3):338-41. PubMed ID: 7786083 [TBL] [Abstract][Full Text] [Related]
10. Developing an anemia management protocol. Case study of the anemic patient. Hossli S ANNA J; 1997 Dec; 24(6):678-84; quiz 685. PubMed ID: 9444110 [TBL] [Abstract][Full Text] [Related]
11. The effect of epoetin dose on hematocrit. Cotter D; Zhang Y; Thamer M; Kaufman J; HernĂ¡n MA Kidney Int; 2008 Feb; 73(3):347-53. PubMed ID: 18004296 [TBL] [Abstract][Full Text] [Related]
12. Nursing care of predialysis patients receiving epoetin alfa. Brown JM ANNA J; 1991 Jun; 18(3):306-14. PubMed ID: 2064456 [TBL] [Abstract][Full Text] [Related]
13. Case management of the anemic patient: epoetin alfa--focus on osteitis fibrosa. Morley CT ANNA J; 1993 Oct; 20(5):604-7. PubMed ID: 8285805 [TBL] [Abstract][Full Text] [Related]
14. Anemia management of adult hemodialysis patients in the US results: from the 1997 ESRD Core Indicators Project. Frankenfield D; Johnson CA; Wish JB; Rocco MV; Madore F; Owen WF Kidney Int; 2000 Feb; 57(2):578-89. PubMed ID: 10652035 [TBL] [Abstract][Full Text] [Related]
16. Monitoring considerations in recombinant human erythropoietin therapy. Ogden DA Semin Nephrol; 1989 Mar; 9(1 Suppl 2):12-5. PubMed ID: 2669080 [TBL] [Abstract][Full Text] [Related]
17. Case study of the anemic patient: epoetin alfa--focus on iron management. Kirlin LF ANNA J; 1995 Apr; 22(2):192-5. PubMed ID: 7786067 [TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of epoetin alfa therapy for anemia of end-stage renal disease. Moran LJ; Carey P; Johnson CA Am J Hosp Pharm; 1992 Jun; 49(6):1451-4. PubMed ID: 1529988 [TBL] [Abstract][Full Text] [Related]
19. An open-label, randomized, multicenter, controlled study of epoetin alfa for the treatment of anemia of chronic kidney disease in the long term care setting. Patel M; Thimons DG; Winston JL; Langholff W; McGowan T J Am Med Dir Assoc; 2012 Mar; 13(3):244-8. PubMed ID: 21450214 [TBL] [Abstract][Full Text] [Related]
20. Managing anemia using laboratory trend analysis. Case study of the anemic patient. Aiello J ANNA J; 1999 Aug; 26(4):430-3. PubMed ID: 10838975 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]